Interferon, alpha 13 (IFNA13) (C-Term) Peptide
IFNA13
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN978417
Quick Overview for Interferon, alpha 13 (IFNA13) (C-Term) Peptide (ABIN978417)
Target
IFNA13
(Interferon, alpha 13 (IFNA13))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- ILAVKKYFRR ITLYLTEKKY SPCAWEVVRA EIMRSLSLST NLQERLRRKE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-IFNA13 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- IFNA13 (Interferon, alpha 13 (IFNA13))
-
Background
-
IFNA13 is produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.
Alias Symbols: IFNA1
Protein Size: 189 -
Molecular Weight
- 21 kDa
-
Gene ID
- 3447
-
NCBI Accession
- NM_006900, NP_008831
-
UniProt
- P01562
Target
-
You are here:
